Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
Year: 2015
Type: article
Source: PubMed
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: non-small cell lung cancer, brain metastases, tyrosine kinase inhibitors, EGFR mutation, ALK rearrangement, crizotinib, ceritinib, alectinib, gefitinib, erlotinib, afatinib, whole brain radiotherapy, stereotactic radiosurgery, blood-brain barrier, CNS progression, treatment options, asymptomatic brain metastases
Open Access status: closed
OpenAlex ID: W2205290296
